AutoGenomics Withdraws IPO for Second Time | GenomeWeb

NEW YORK (GenomeWeb News) – AutoGenomics once again withdrew its planned initial public offering after failing to meet a Feb. 15 deadline to provide its latest financial information to the US Securities and Exchange Commission, a company official confirmed to GenomeWeb Daily News.

Ramanath Vairavan, senior vice president of sales and marketing for the Vista, Calif.-based molecular diagnostics firm, said that the company hopes to refile for an IPO in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.